Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan · Delayed Price · Currency is JPY 4,135.00
+95.00 (2.35%)
Jul 14, 2026, 3:30 PM JST
Towa Pharmaceutical Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Towa Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥5,267. The average 1-year stock price forecast is 27.37% higher than the current stock price, while the lowest is ¥4,500 (+8.83%) and the highest is ¥5,900 (+42.68%).
Price Target: ¥5,267 (+27.37%)
Analyst Consensus: Buy
* Price targets were last updated on Jun 12, 2026.
Analyst Ratings
The average analyst rating for Towa Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Upgrades ¥4,500 → ¥5,600 | Buy | Upgrades | ¥4,500 → ¥5,600 | +35.43% | Jun 12, 2026 |
Financial Forecast
Revenue This Year
304.53B
from 273.71B
Increased by 11.26%
Revenue Next Year
320.20B
from 304.53B
Increased by 5.15%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 311.6B | ||
| Avg | 304.5B | ||
| Low | 298.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 13.9% | ||
| Avg | 11.3% | ||
| Low | 9.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2028 | 2029 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |